Related Experiment Video

Updated: Jul 19, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.2K

VIM::KMT2A rearranged sarcoma: a rare emerging entity

Rana Naous1, John M Skaugen1, Megan L Zilla1

  • 1University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Histopathology
|August 14, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

Related Experiment Videos

Last Updated: Jul 19, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.2K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.4K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K

Articles linked to this work by shared authors, journal, and citation graph.

Integrated Clinicopathological and Multiomic Profiling Reveals MEIS1-rearranged Sarcoma as a Distinct Entity with Two Prognostic Subgroups.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Primary intracranial sarcoma, DICER1-mutant: 5 cases highlighting variable clinical and molecular features.

Journal of neuropathology and experimental neurology·2026

The utility of clonal relatedness molecular testing in cytology: An institutional experience.

Annals of diagnostic pathology·2026

Clinical Outcomes and Prognostication of CRTC1::TRIM11 Fusion Cutaneous Tumors.

The American journal of surgical pathology·2026

Intramuscular myxoma with chondroid features: two cases expanding the morphological spectrum.

Histopathology·2026

Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.

Nature medicine·2026

Comprehensive and reproducible grading of the Updated Sydney System in gastric biopsies using artificial intelligence: multi-pathologist validation and a reader study.

Histopathology·2026

Spermatocytic tumours containing an intratubular component: a multi-institutional study emphasizing diagnostic pitfall with germ cell neoplasia in situ.

Histopathology·2026

Intratumoral IDH1 mutation status in intrahepatic cholangiocarcinoma is homogeneous.

Histopathology·2026

Novel and emerging cutaneous soft tissue tumours.

Histopathology·2026

Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB-amplified renal cell carcinoma: a comprehensive study of 15 cases.

Histopathology·2026

HMGA2 is a highly sensitive marker for DICER1-related tumours.

Histopathology·2026

Invasive pulmonary aspergillosis following mild Covid-19 in an autologous hematopoietic stem cell transplant recipient: A case report.

Medical mycology case reports·2026

Secondary Staphylococcus capitis Infection of a Long-Standing Non-Coronary Sinus of Valsalva-to-Right Atrial Fistula Initially Misdiagnosed as a Gerbode Defect: A Case Report.

Journal of clinical medicine·2026

Retraction notice to "Mathematical modeling and QSPR analysis of hepatitis treatment drugs through connection indices an innovative approach" [Heliyon 11 (2025) e41234].

Heliyon·2026

Retraction notice to "The gingival crevicular fluid biomarkers with micropulse vibration device: A pilot study" [Heliyon 10 (2024) e31982].

Heliyon·2026

Retraction notice to "A review on surface modification of nanofibrous textiles for diverse applications: Focus on medical uses" [Heliyon 11 (2025) e41863].

Heliyon·2026

Moraxella nonliquefaciens Keratitis Due to Ocular Surface Disease in a Patient Treated with Zanubrutinib for Mantle Cell Lymphoma.

Eye & contact lens·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us